GL1X · GenesisL1 explorer

MolNFT v1 · #118841 · protein

Crystal structure of human pcaf bromodomain in complex with compound SL1122 (compound 13)

5FE9 · Histone acetyltransferase KAT2B: “Crystal structure of human pcaf bromodomain in complex with compound SL1122 (compound 13)”. X-ray diffraction, 1 ligand (5WS), 3 pockets (best druggability 0.66). MolNFT v1 #118841 on GenesisL1: 3D…

PDB
5FE9
Type
protein
Length
218 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Histone acetyltransferase KAT2B
EC
2.3.1.48
UniProt
Q92831
Ligands
5WS
Pockets
3 · best druggability 0.66

Structure

x-ray diffraction · 1 distinct chain · 68% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BHistone acetyltransferase KAT2B (EC 2.3.1.48)protein10968% helix, 0% strandQ92831

Ligands and binding sites

  • 5WS · ~{N}-(1,4-dimethyl-2-oxidanylidene-quinolin-7-yl)methanesulfonamide · ligand · 2 copies · chains A, B
  • EDO · 1,2-ethanediol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14690.660.7734empty
21330.520.80195WS
31170.510.81185WS

Interfaces

1 interface between chains.

  • A–B · 820 Ų buried · 12 hydrogen bonds · protein-protein

Compared structures

  • 5FE9 · Crystal structure of human PCAF bromodomain in complex with compound SL1122 (compound 13) · the same entry in another collection · chain A against A, TM-score 1.00
  • Q92831 · AlphaFold monomer V2.0 prediction for histone acetyltransferase KAT2B (Q92831) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.